[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$tmdxs Graphic](https://lunarcrush.com/gi/w:26/t:$tmdxs.png) $tmdxs

$TMDX is expanding into Italy with new hospitals and a manufacturing hub, and its logistics platform is highlighted as a key competitive advantage.

### About $tmdxs
A cryptocurrency project.  

### Insights [#](/topic/$tmdxs/insights)
- $tmdxs engagements is up XXXXXXXX% from the previous week.

### Engagements: XXX [#](/topic/$tmdxs/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$tmdxs/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$tmdxs/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXX +1,488%  
**1 Month**: XXXXX -XX%  
**1-Year High**: XXXXX on 2025-07-31  
**1-Year Low**: X on 2025-07-22  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$tmdxs/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$tmdxs/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$tmdxs/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Month**: X no change  
**1-Year High**: X on 2025-09-09  
**1-Year Low**: X on 2025-04-27  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$tmdxs/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$tmdxs/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$tmdxs/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $tmdxs in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1 Month**: X no change  
**1-Year High**: X on 2025-07-17  
**1-Year Low**: X on 2025-04-27  

The most influential creators that mention $tmdxs in the last XX hours

| Creator                                      | Rank | Followers | Posts | Engagements |
| -------                                      | ---- | --------- | ----- | ----------- |
| [@mathlonning](/creator/twitter/mathlonning) | X    | XXX       | X     | X           |

[View More](/list/creators/$tmdxs/100)

**Top assets mentioned**
In the posts about $tmdxs in the last XX hours

[TransMedics Group, Inc. Common Stock (TMDX)](/topic/$tmdx)

**Top topics mentioned**
In the posts about $tmdxs in the last XX hours

[$tmdx](/topic/$tmdx), [adoption](/topic/adoption), [hub](/topic/hub), [replicate](/topic/replicate), [$4543t](/topic/$4543t), [$srta](/topic/$srta), [$30m](/topic/$30m), [$23m](/topic/$23m)

### Top Social Posts [#](/topic/$tmdxs/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"If you have not seen $TMDX's award winning state-of-the-art Command Center and operations team that is the center of all organ transporting operations for $TMDX watch it here now and be amazed 👇 $TMDX is disrupting the entire organ transplant industry 🔥"  
[X Link](https://x.com/KabraxFX/status/1974636828268576985) [@KabraxFX](/creator/x/KabraxFX) 2025-10-05T00:44Z 4125 followers, 6264 engagements


"10/ $SRTA: Assuming Strata + Keystone can grow 2026 EBITDA XX% YoY to $30M from $23M which is similar to $TMDX and using $TMDX's 23x 2026E EBITDA multiple gets you to around $XXXX per share for Strata The key will be where they guide 2026 at the November investor day🔥. Also with well over $100M in cash will they execute another deal in the coming weeks"  
[X Link](https://x.com/spacanpanman/status/1968669252325380527) [@spacanpanman](/creator/x/spacanpanman) 2025-09-18T13:31Z 33.6K followers, 5525 engagements


"COMPETITORS In the organ preservation and transplantation sector $TMDX faces competition from companies like XVIVO Perfusion and OrganOx (recently acquired by Terumo). While both have established technologies $TMDX's Organ Care System (OCS) offers distinct advantages in terms of organ viability and clinical adoption. XVIVO Perfusion XVIVO specializes in ex-vivo lung perfusion (EVLP) with its XPS platform and offers hypothermic oxygenated perfusion (HOPE) solutions for liver preservation. The XPS system is widely used for lung transplants providing a comprehensive platform for assessing and"  
[X Link](https://x.com/mathlonning/status/1962265832442286373) [@mathlonning](/creator/x/mathlonning) 2025-08-31T21:26Z XXX followers, XXX engagements


"LOGISTICS MOAT (NOP)🏥 $TMDXs logistics platform is a key part of its competitive moat. Its 24/7 hub coordinates organ retrieval and transport nationwide ensuring that donor organs can be matched with the right patients anywhere in the U.S. in real time. This level of responsiveness is difficult for competitors to replicate and drives higher adoption among transplant centers. The integrated TMDX NOP (Network Operations Platform) further enhances convenience for clinicians providing streamlined scheduling monitoring and device management. By reducing operational friction for doctors and"  
[X Link](https://x.com/mathlonning/status/1962265829757862218) [@mathlonning](/creator/x/mathlonning) 2025-08-31T21:26Z XXX followers, XXX engagements